Clinical trial
Acute Kidney Injury and Intermittent Dialysis Dose
NCT07924137 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Kidney Injury and Intermittent Dialysis Dose
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- January 1, 2028
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, critical illness, intensive care (icu), renal dialysis, renal replacement therapy
Arms
As registered; 1 arm.
-
Patients on intermittent hemodialysis
Adult ICU patients with KDIGO stage 3 AKI treated with IHD, either first-line or following continuous kidney replacement therapy.
In these patients, the study assesses the agreement between different measures of dialysis dose (Kt/Vd, double-pool Kt/Vd, Kt, URR, SRI).
Primary endpoints
Registered primary outcome measures; 5 primary.
-
Kt: volume of blood totally cleared of urea during the session (L)
Quantitative value of each dialysis dose parameter, measured at each dialysis session
-
Kt/Vd: Kt divided by the patient's urea distribution volume (Vd, L)
Quantitative value of each dialysis dose parameter, measured at each dialysis session
-
Double-pool Kt/Vd: Kt/Vd calculated with a double-pool urea kinetic model
Quantitative value of each dialysis dose parameter, measured at each dialysis session
-
URR: urea reduction ratio, based on post-dialysis plasma urea
Quantitative value of each dialysis dose parameter, measured at each dialysis session
-
SRI: solute removal index, based on urea in the effluent
Quantitative value of each dialysis dose parameter, measured at each dialysis session
Lead sponsor's other trials
Assistance Publique - Hôpitaux de Paris, most recent start first.
+3,590 more trials See the organization page
Similar trials
Same condition (Acute Kidney Injury) and phase, most recent start first.
+792 more trials See the condition page